Alexandre de Mendonça Selected Research

Pharmaceutical Preparations

1/2022

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre de Mendonça Research Topics

Disease

25	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2007
19	Cognitive Dysfunction 01/2022 - 01/2004
18	Frontotemporal Dementia (Semantic Dementia) 08/2022 - 01/2013
15	Dementia (Dementias) 01/2022 - 09/2006
8	Atrophy 01/2022 - 02/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2007
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2017
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 12/2007
2	Disease Progression 01/2022 - 12/2019
2	Amyloid Plaque 01/2022 - 01/2018
2	Multiple Sclerosis 01/2017 - 12/2007
2	Amyloidosis 01/2016 - 02/2015
2	Nervous System Diseases (Neurological Disorders) 12/2007 - 03/2003
1	Gliosis 01/2022
1	Hearing Loss (Hearing Impairment) 09/2021
1	Tinnitus 09/2021
1	Cerebral Cortical Thinning 01/2021
1	Genetic Risk Score 01/2021
1	Tauopathies 11/2019
1	Neurobehavioral Manifestations 01/2018
1	Memory Disorders (Memory Loss) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Headache (Headaches) 02/2016
1	Back Pain (Backache) 02/2016
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016
1	Disease Susceptibility (Diathesis) 09/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 09/2014
1	Primary Progressive Aphasia 01/2012
1	Brain Injuries (Brain Injury) 12/2007
1	Stroke (Strokes) 12/2007
1	Huntington Disease (Huntington's Disease) 12/2007
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 09/2006
1	Hyponatremia 09/2006
1	Hyperthyroidism 09/2006
1	Renal Insufficiency (Renal Failure) 09/2006

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2014
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2015
6	ProgranulinsIBA 08/2022 - 01/2013
4	GranulinsIBA 01/2022 - 01/2021
4	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2015
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2022 - 01/2017
3	Caffeine (No Doz)FDA LinkGeneric 01/2010 - 01/2010
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	sortilinIBA 01/2018 - 01/2016
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018 - 01/2016
2	IronIBA 10/2015 - 04/2014
1	antineoplaston A10 (A 10)IBA 01/2022
1	neuronal pentraxinIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	sharpinIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2018
1	T-Cell Intracellular Antigen-1IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Nonsense Codon (Nonsense Mutation)IBA 09/2017
1	ImmunosorbentsIBA 01/2016
1	EnzymesIBA 01/2016
1	Phospholipases (Phospholipase)IBA 12/2015
1	Messenger RNA (mRNA)IBA 10/2015
1	Pemetrexed (MTA)FDA Link 02/2015
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	ElementsIBA 08/2011
1	LigandsIBA 12/2007
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2007
1	Adenosine (Adenocard)FDA LinkGeneric 12/2007
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2007
1	CholesterolIBA 09/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2003

Therapy/Procedure

1	Hearing Aids (Hearing Aid) 09/2021
1	Precision Medicine 11/2019
1	Punctures 02/2016
1	Long-Term Care 07/2013
1	Speech Therapy (Therapy, Speech) 01/2012
1	Activities of Daily Living (ADL) 01/2004